|
|
|
Bright Minds Biosciences Inc (DRUG) |
|
Bright Minds Biosciences Inc
Officers & Directors
News about Bright Minds Biosciences Inc Key Personnel |
Bright Minds Biosciences: A $35 Million Gamble Amidst Dismal Financials and Industry CompetitionIn an audacious move that has raised eyebrows among investors and market analysts alike, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has closed a non-brokered private placement, securing $35 million by selling 1,612,902 common shares at a price of $21.70 each. The announcement, made on November 4, 2024, marks a significant financial maneuver for the Vancouver-based biotech company, especially considering its recent performance and the fiercely competitive landscape it faces.This considerable influx of cash comes on the heels of the company reporting a cumulative net loss of $6 million during the 12 mo...
|
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
